Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-ROR1 CAR-T cells: Architecture and performance. | Front Med (Lausanne) | 2023 | 36873868 | PubTator, text mining | PubMed |
| Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo. | Mol Biomed | 2023 | 36871129 | PubTator, text mining | PubMed |
| A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development. | J Pharmacokinet Pharmacodyn | 2023 | 36870005 | PubTator, text mining | PubMed |
| CD19 CAR antigen engagement mechanisms and affinity tuning. | Sci Immunol | 2023 | 36867678 | PubTator, text mining | PubMed |
| Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy. | Tissue Eng Regen Med | 2023 | 36867402 | PubTator, text mining | PubMed |
| Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2023 | 36860867 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors. | Front Immunol | 2023 | 36860862 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| 'Off the shelf' immunotherapies: Generation and application of pluripotent stem cell-derived immune cells. | Cell Prolif | 2023 | 36855955 | PubTator, text mining | PubMed |
| CAR-T Therapies in Solid Tumors: Opportunities and Challenges. | Curr Oncol Rep | 2023 | 36853475 | PubTator, text mining | PubMed |
| CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. | Vaccines (Basel) | 2023 | 36851194 | PubTator, text mining | PubMed |
| Highlights into historical and current immune interventions for cancer. | Int Immunopharmacol | 2023 | 36848790 | PubTator, text mining | PubMed |
| A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma. | Front Oncol | 2023 | 36845727 | PubTator, text mining | PubMed |
| Correlation evaluation between cancer microenvironment related genes and prognosis based on intelligent medical internet of things. | Front Genet | 2023 | 36845384 | PubTator, text mining | PubMed |
| Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia. | Front Immunol | 2023 | 36845088 | PubTator, text mining | PubMed |
| Best of hematology-2021. | Memo | 2023 | 36844902 | PubTator, text mining | PubMed |
| mRNA-Based Therapeutics in Cancer Treatment. | Pharmaceutics | 2023 | 36839944 | PubTator, text mining | PubMed |
| Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer. | Molecules | 2023 | 36838790 | PubTator, text mining | PubMed |
| 4-1BB-Based CAR T Cells Effectively Reverse Exhaustion and Enhance the Anti-Tumor Immune Response through Autocrine PD-L1 scFv Antibody. | Int J Mol Sci | 2023 | 36835603 | PubTator, text mining | PubMed |
| Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties. | Int J Mol Sci | 2023 | 36835110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=38